Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tatsuhiko Azegami

Showing results (91-100 of 99) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 99 results.
Aging Cell|April 22, 2026
The Mitochondrial NAD Transporter SLC25A51 in Adipocytes Regulates Adipose Tissue Mitochondrial Function and Systemic Metabolism During AgingDaiki Kojima, Keisuke Yaku, Shotaro Kosugi, et al.
Scientific Reports|October 10, 2024
Clinical relevance of proteinuria selectivity index and fractional excretion of sodium in patients with nephrotic syndromeTakashin Nakayama, Tatsuhiko Azegami, Shintaro Yamaguchi, et al.
Clinical and Experimental Nephrology|September 23, 2025
Urine-to-blood urea nitrogen ratio predicts proteinuria remission in nephrotic syndromeRyunosuke Mitsuno, Takashin Nakayama, Ryuto Yoshida, et al.
CEN Case Reports|April 16, 2025
Taurine supplementation improves physical activity level in a hemodialysis patient with mitochondrial disease: a case reportRyuto Yoshida, Ryunosuke Mitsuno, Takashin Nakayama, et al.
Kidney International Reports|July 18, 2025
Erratum to "Open-Label, Randomized, Controlled, Crossover Trial on the Effect of Dapagliflozin in Patients With ADPKD Receiving Tolvaptan" [<i>Kidney International Reports</i> Volume 10, Issue 4, April 2025, Pages 1063-1075]Kiyotaka Uchiyama, Daisuke Kamano, Tomoki Nagasaka, et al.
Kidney International Reports|April 30, 2025
Open-Label, Randomized, Controlled, Crossover Trial on the Effect of Dapagliflozin in Patients With ADPKD Receiving TolvaptanKiyotaka Uchiyama, Daisuke Kamano, Tomoki Nagasaka, et al.
Kidney360|October 6, 2025
Association Between Urinary Fractional Excretion of Potassium and Proteinuria Remission in Adult Nephrotic SyndromeRyuto Yoshida, Takashin Nakayama, Ryunosuke Mitsuno, et al.
Internal Medicine (Tokyo, Japan)|June 21, 2021
SARS-CoV-2 Infection among Medical Institution Faculty and Healthcare Workers in Tokyo, JapanTomoyasu Nishimura, Yoshifumi Uwamino, Shunsuke Uno, et al.
Kidney Medicine|April 22, 2026
Association Between Microscopic Hematuria and Proteinuria Remission in Adult Nephrotic SyndromeRyuto Yoshida, Ryunosuke Mitsuno, Takashin Nakayama, et al.
Pageof 10

Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
Aging Cell|April 22, 2026
The Mitochondrial NAD Transporter SLC25A51 in Adipocytes Regulates Adipose Tissue Mitochondrial Function and Systemic Metabolism During AgingDaiki Kojima, Keisuke Yaku, Shotaro Kosugi, et al.
Scientific Reports|October 10, 2024
Clinical relevance of proteinuria selectivity index and fractional excretion of sodium in patients with nephrotic syndromeTakashin Nakayama, Tatsuhiko Azegami, Shintaro Yamaguchi, et al.
Clinical and Experimental Nephrology|September 23, 2025
Urine-to-blood urea nitrogen ratio predicts proteinuria remission in nephrotic syndromeRyunosuke Mitsuno, Takashin Nakayama, Ryuto Yoshida, et al.
CEN Case Reports|April 16, 2025
Taurine supplementation improves physical activity level in a hemodialysis patient with mitochondrial disease: a case reportRyuto Yoshida, Ryunosuke Mitsuno, Takashin Nakayama, et al.
Kidney International Reports|July 18, 2025
Erratum to "Open-Label, Randomized, Controlled, Crossover Trial on the Effect of Dapagliflozin in Patients With ADPKD Receiving Tolvaptan" [<i>Kidney International Reports</i> Volume 10, Issue 4, April 2025, Pages 1063-1075]Kiyotaka Uchiyama, Daisuke Kamano, Tomoki Nagasaka, et al.
Kidney International Reports|April 30, 2025
Open-Label, Randomized, Controlled, Crossover Trial on the Effect of Dapagliflozin in Patients With ADPKD Receiving TolvaptanKiyotaka Uchiyama, Daisuke Kamano, Tomoki Nagasaka, et al.
Kidney360|October 6, 2025
Association Between Urinary Fractional Excretion of Potassium and Proteinuria Remission in Adult Nephrotic SyndromeRyuto Yoshida, Takashin Nakayama, Ryunosuke Mitsuno, et al.
Internal Medicine (Tokyo, Japan)|June 21, 2021
SARS-CoV-2 Infection among Medical Institution Faculty and Healthcare Workers in Tokyo, JapanTomoyasu Nishimura, Yoshifumi Uwamino, Shunsuke Uno, et al.
Kidney Medicine|April 22, 2026
Association Between Microscopic Hematuria and Proteinuria Remission in Adult Nephrotic SyndromeRyuto Yoshida, Ryunosuke Mitsuno, Takashin Nakayama, et al.
Pageof 10